Trials / Not Yet Recruiting
Not Yet RecruitingNCT05510830
Diagnostic Cervical Conization for Persistent Infection or Integration of HPV
A Study of the Value of Diagnostic Cervical Conization for Persistent Infection or Integration of Human Papillomavirus
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 250 (estimated)
- Sponsor
- Tongji Hospital · Academic / Other
- Sex
- Female
- Age
- 25 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
For the patients with cervical persistent infection or integration of HPV, we has designed a program to perform cervical conization for certain patients to earlier and better diagnose and cure the diseases of HPV infection and related cervical intraepithelial neoplasia/cancer.
Detailed description
For the patients with cervical persistent infection or integration of human papillomavirus, the incidence of suffering cervical cancer or percancerous lesions increases. As the biopsy guided by colposcopy might miss some lesions, the cervical conization plays a role for the patients with high risk factors to diagnose the related cervical diseases. In this study, we has designed a program to perform cervical conization for certain patients to earlier and better diagnose and cure the diseases of HPV infection and related cervical intraepithelial neoplasia/cancer.
Conditions
- Human Papilloma Virus Infection
- Human Papilloma Virus Integration
- Cervical Intraepithelial Neoplasia
- Cervical Cancer
- Cervical Conization
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | diagnostic cervical conization | For the patients who met the inclusion criteria, the gynecologists perform cervical conization and pathological examinations. Then the patients will be followed-up for at least two years with the tests of cervical TCT \& HPV, and colposcopy if necessary. The data will be analyzed and see if the patients with high risk factors benefit from the surgery or not. |
Timeline
- Start date
- 2022-10-01
- Primary completion
- 2028-01-01
- Completion
- 2030-01-01
- First posted
- 2022-08-22
- Last updated
- 2022-09-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05510830. Inclusion in this directory is not an endorsement.